Tweet
More research is needed into a controversial fertility treatment, known as three-parent IVF, before it can be considered safe for clinical use, a review has concluded.
Mothers carrying faulty mitochondria in their eggs are at risk of having children with the inherited disorder.Under the transfer treatment, the idea is to replace the faulty mitochondria in the eggs or fertilised embryos with those from eggs or early embryos from a healthy, unaffected donor.
Mitochondrial transfer aims to replace a faulty part of a mother's egg with healthy material from a donor. This means a baby would have a small amount of the donor's genetic material, and therefore three biological parents.
The Human Fertilisation and Embryology Authority (HFEA) carried out the study. The HFEA is the UK's fertility treatment regulator and its conclusions are published in a scientific review of the technique commissioned by the Department for Health.
Source: BBC
Read more.
Mothers carrying faulty mitochondria in their eggs are at risk of having children with the inherited disorder.Under the transfer treatment, the idea is to replace the faulty mitochondria in the eggs or fertilised embryos with those from eggs or early embryos from a healthy, unaffected donor.
Mitochondrial transfer aims to replace a faulty part of a mother's egg with healthy material from a donor. This means a baby would have a small amount of the donor's genetic material, and therefore three biological parents.
The Human Fertilisation and Embryology Authority (HFEA) carried out the study. The HFEA is the UK's fertility treatment regulator and its conclusions are published in a scientific review of the technique commissioned by the Department for Health.
Source: BBC
Read more.
